Skip to main content

Profile: Kim Birtcher

Kimberly Birtcher
Kim K. Birtcher, Pharm.D., M.S., BCPS, CDE, CLS
Clinical Professor
Department of Pharmacy Practice and Translational Research
University of Houston College of Pharmacy
Health and Biomedical Sciences Building 2, Room 4016
4849 Calhoun
College of Pharmacy
Houston, TX 77204-5000

832-842-8372
Fax: 832-842-8383
kbirtcher@uh.edu

Education

Pharm.D., University of Florida, Gainesville, Florida

M.S., Pharmacy Administration, The University of Texas, Austin, Texas

B.S., Pharmacy, The University of Texas, Austin, Texas

Additional Certifications and Qualifications

Associate of the American College of Cardiology (AACC), May 2010

Fellow of the American Heart Association (FAHA), December 2009

Fellow of the National Lipid Association (FNLA), May 2009

Clinical Lipid Specialist, Diplomate status with the Accreditation Council for Clinical Lipidology, 2007

Certified Diabetes Educator (CDE), 2005 – present

Immunizations Provider, 2004 - present

Board Certified Pharmacotherapy Specialist with Added Qualifications in Cardiology, 2001 – present

Basic Cardiac Life Support, 1980 - present

Research Interests

  • Cardiovascular diseases
  • Diabetes
  • Continuous Quality Improvement

Courses

  • Practice
  • Therapeutics
  • Rotations

Awards & Honors

  • Teaching Excellence Award, Rho Chi Society at University of Houston College of Pharmacy, September 2016
  • Appointed to Joint American College of Cardiology/American Heart Association Taskforce on Practice Guidlines, 2015
  • Teaching Excellence Award, Rho Chi Society at University of Houston College of Pharmacy, November 2014
  • Faculty Preceptor Award, University of Houston College of Pharmacy, May 2012
  • Honorable Mention, Teaching Excellence Award, UH Beta Omicron Chapter, The Rho Chi Society, 2011
  • Outstanding Pharmacist of the Year, Gulf Coast Society of Health-System Pharmacists, 2010
  • Rho Chi Teaching Excellence Award, UH Beta Omicron Chapter, The Rho Chi Society, 2009
  • 2nd Place Poster, “Potential Interaction Between Clopidogrel and Proton Pump Inhibitors”, Kelsey Research Foundation Health Services & Outcomes Research Conference, December 2, 2009, Houston, Texas
  • Faculty Service Excellence Award, University of Houston College of Pharmacy, May 2009
  • Phi Lambda Sigma Faculty Leadership Award, University of Houston College of Pharmacy, May 2009
  • Certificate of Recognition, Rho Chi Teaching Excellence Award, University of Houston College of Pharmacy, May 2008
  • Nominee, Outstanding Pharmacist, Gulf Coast Society of Health-System Pharmacists, February 2008
  • Faculty Preceptor Award, University of Houston College of Pharmacy, May 2008
  • 2007 Texas Cardiovascular Health Promotion Awards Outstanding Program – “University of Houston College of Pharmacy, Kelsey Seybold Clinic, and Kelsey Research Foundation's Secondary Prevention Lipid Clinic – from Texas Council on Cardiovascular Disease and Stroke
  • 2nd Place Poster, “Secondary Prevention Lipid Clinic Provides Influenza Vaccinations to High Risk Patients with Coronary Heart Disease”, Kelsey Research Foundation Health Services & Outcomes Research Conference, November 6, 2007, Houston, Texas
  • “Faculty Member Who Inspires Us” Award, University of Houston College of Pharmacy’s Class of 2006, May 2006
  • Nominee, Faculty Teaching Award, University of Houston College of Pharmacy, March 2006
  • Finalist, 2005-06 Teaching Excellence Award, University of Houston
  • Distinguished Service Award, American Heart Association – Texas Affiliate, January 17, 2006
  • Finalist, University of Houston 2005 – 2006 Teaching Excellence Award
  • 2nd Place Poster, “Influenza Vaccination Rates in High-risk Cardiovascular Patients Before and After a Pharmacist Vaccination Program”, Kelsey Research Foundation Health Services & Outcomes Research Conference, November 9, 2005, Houston, Texas
  • Faculty Teaching Award, University of Houston College of Pharmacy, May 2005
  • Faculty Preceptor Award, University of Houston College of Pharmacy’s Class of 2005, May 2005
  • Inducted, Phi Lambda Sigma (National Honorary Leadership Society) at University of Houston College of Pharmacy, March 2005
  • Recognized Secondary Prevention Lipid Clinic at Kelsey-Seybold Clinic as a program of excellence in quality patient care, American Medical Group Association, January 2005
  • Nominee, Texas Society of Health-Systems Pharmacists’ Lewis S. Smith Pharmacy Practitioner Award, March 2004
  • 2nd Place Poster, “Prevention of Secondary Cardiovascular Events by Risk Factor Modification with a Lipid Clinic”, Kelsey Research Foundation Health Services & Outcomes Research Conference, November 3, 2003, Houston, Texas
  • Teaching Excellence Award, Rho Chi Society at University of Houston College of Pharmacy, May 2003
  • Nominee, American Heart Association Texas Affiliate’s Walter M. Kirkendall award for service, May 2003
  • Outstanding Doctor of Pharmacy Graduating Student award, University of Florida Working Professional Pharmacy Program, December 2000

Selected Peer-reviewed Publications

Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly Jr DD, DePalma SM, Minissian, MB, Orringer CE, Smith Jr SC. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk. Journal of the American College of Cardiology (2016), DOI: 10.1016/j.jacc.2016.03.519.

Birtcher KK, Morris PB, Martin SS, Blumenthal RS. Drug Safety and Efficacy: Treatments for Very High Triglycerides. http://www.acc.org/. December 14, 2015. http://www.acc.org/latest-in-cardiology/articles /2015/12/14/10/39/drug-safety-and-efficacy-treatments-for-very-high-triglycerides.

Dunn SP,Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL, Bittner V, Walsh MN. The Role of the Clinical Pharmacist in the Care of Patients With Cardiovascular Disease . J Am Coll Cardiol 2015;66:2129–39.

JE Brush Jr, EM Handberg, C Biga, KK Birtcher, AA Bove, PN Casale, MG Clark, A Garson Jr, JL Hines, JA Linderbaum, GP Rodgers, RA Shor, VH Thourani, JF Wyman. 2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers. Am Coll Cardiol 2015;65:2119-36.

RJ Kovacs, GC Flaker, SJ Saxonhouse, JU Doherty, KK Birtcher, A Cuker, BL Davidson, RP Giugliano, CB Granger, AK Jaffer, BH Mehta, E Nutescu, KA Williams. Practical Management of Anticoagulation in Patients With Atrial Fibrillation. Am Coll Cardiol 2015;65:1340–60.

K Birtcher. When Compliance Is an Issue—How to Enhance Statin Adherence and Address Adverse Effects. Current Atherosclerosis Report. 2015;17:471. DOI 10.1007/s11883-014-0471-8.

A Miller, M. Sobhanian, KK. Birtcher. Triglycerides - What's Your Number patient tear sheet. Lipid Spin 2014;12,37 and http://db.lipid.org/marketing/meetings_2014/Triglyceride-Patient-Sheet.pdf; September 2014.

PB Morris, CM Ballantyne, KK Birtcher, SP Dunn, EM Urbina. Review of Clinical Practice Guidelines for the Management of LDL-Related Risk. Journal of the American College of Cardiology 2014; 64 (2): 196-206.

KK Birtcher, W Pan, KA LaBresh, CP Cannon, GC Fonarow, G Ellrodt. Performance Achievement Award Program for Get With The Guidelines - Coronary Artery Disease Is Associated With Global and Sustained Improvement in Cardiac Care For Patients Hospitalized With An Acute Myocardial Infarction; Critical Pathways in Cardiology 2010 Sep;9(3):103-12.

KK Birtcher, AJ Greisinger,  BJ  Brehm, OA Wehmanen, LM Furman CC Salinas, M Mirzai-Tehrane, A Nayak, H Rashid, A Mortazavi. A Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Cardiology Care For Patients With Coronary Heart Disease. Journal of Clinical Lipidology 2010 Jan-Feb;4(1):46-52.

Birtcher KK, Corbett SM, Pass SE, Coyle EA, Yeh RF, Tipton J, Garey KW. Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians. Academic Pharmacy Symposium. Am J Health Syst Pharm. 2010 Feb 1;67(3):231-8. PMID: 20101067

Albert NM, Birtcher KK, Cannon CP, Goff DC Jr, Mulgund J, Liang L, Fonarow GC. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database). Am J Cardiol. 2008 May 1;101(9):1242-6. Epub 2008 Mar 5. PMID: 18435951

S.M. Loughlin, A. Mortazavi, K.W. Garey, G.K. Rice, and K.K. Birtcher. Pharmacist-Managed Vaccination Program Increased Influenza Vaccination Rates in Cardiovascular Patients Enrolled in a Secondary Prevention Lipid Clinic, Pharmacotherapy 2007, 27(5): 729–733.

M.K. Ito, R.J. Cheung, E.K. Gupta, K.K. Birtcher, P.H. Chong, T.M. Bianco, B.E. Bleske. Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias. Pharmacotherapy, 26(7): 939–1010, 2006.

P.R. Wigle, K.K. Birtcher. What’s New?—Guidelines and Goals, Journal of Pharmacy Practice, 19, 2: 1–10, 2006.

Other Publications

My Clinician Wants Me to Take a Statin, Patient-Centered Education from the National Lipid Association tear sheet; KK. Birtcher; Lipid Spin 2016. https://www.lipid.org/practicetools/tools/tearsheets;posted 2016

Pharmacist-Patient Guide for Safe Use of Fish Oil and Omega-3 Supplements; American Pharmacists Association Practice Tools;http://pharmacist.com/practice-tools;July 2015

Triglycerides - What's Your Number patient tear sheet; A Miller, M. Sobhanian, KK. Birtcher; Lipid Spin 2014;12,37 and http://db.lipid.org/marketing/meetings_2014/ Triglyceride-Patient-Sheet.pdf; September 2014

Clinical Significance – Clinical Significance and Clinical Scenario for the “Diuretics” chapter, Foye’s Principles of Medicinal Chemistry, 7th edition, Lippincott, Williams, and Wilkins, 2011

Clinical Significance – Clinical Significance and Clinical Scenario for the “Antithrombotics, Thrombolytics, Coagulants, and Plasma Extenders” chapter, Foye’s Principles of Medicinal Chemistry, 7th edition, Lippincott, Williams, and Wilkins, 2011

“Initiating and Monitoring Statin Therapy”; On-line Educational resource in Atherosclerosis; Lipids Online (www.lipidsonline.com); posted July 2009

Clinical Significance – chapter introduction to Diuretics chapter, Foye’s Principles of Medicinal Chemistry, 6th edition, Lippincott, Williams, and Wilkins, 2007

Clinical Significance – chapter introduction to Diabetes chapter, Foye’s Principles of Medicinal Chemistry, 6th edition, Lippincott, Williams, and Wilkins, 2007

Tutorial 4: Dosing Strategies: Rationale for Intensive Statin Therapy- Online Continuing Medical Education, K.K. Birtcher, M. Miller, www.eslm.org, June 2006

Omega-3 Fatty Acids and Cardiovascular Prevention, K. Birtcher, Lipid Letter, 2006:5:3-5.

Screening Cholesterol & Point-of-Care Cholesterol Measurement, K. Birtcher, Texas Pharmacy, Winter 2006

Case 30: Refractory Mixed Hyperlipidemia and Vitamin Use – Online Continuing Medical Education (Grand Rounds), K. Birtcher, www.eslm.org, September 2005

Book Chapters

Clinical Evaluation and Treatment of the Adult Patient, Chapter in Pharmacist’s Guide to Lipid Management (Second Edition). Lenexa, KS: American College of Clinical Pharmacy, 2014, pp. 22-31.

Clinical Evaluation of the Adult Patient, chapter in Pharmacist’s Guide to Lipid Management. Lenexa, KS: American College of Clinical Pharmacy, 2008, pp. 20-29.

Poster Presentations

Hypertriglyceridemia and CVD Risk: Are Triglycerides Rocking the Cardiovascular Boat?; American Society of Health-System Pharmacists; Anaheim, California; December 9, 2014.

Secondary Prevention Lipid Clinic Identifies Patients With Low Vitamin D Levels; Loriann M. Furman, Kim K. Birtcher, Natasha Jackson, Cathryn C. Salinas, Atasu Nayak, Haroonur Rashid, Pablo Lozano, Ali Mortazavi; a poster presentation at the 12th Annual Health Services and Outcomes Research Conference: Health Care Reform: The Evolving Implications for Quality of Care and Research; Houston, Texas; November 16, 2011

Nanita Garg, Natasha M.S. Jackson, Cathryn C. Salinas, Kim K. Birtcher, Jeffrey T. Sherer, Tom Thomas.  “Evaluation of changes in bone mineral density scores in patients referred to an osteoporosis care clinic service” (resident poster presentation), ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2009; and 10th Annual Health Services and Outcomes Research Conference: Improving the Quality of Health Care: The Patient’s Perspective, Houston, Texas, December 2, 2009.

Kim K. Birtcher; Anthony Greisinger; Brenda J. Brehm; Oscar Wehmanen; Loriann M. Furman; Cathryn C. Salinas; Madjid Mirzai-tehrane; Atasu Nayak; Haroonur Rashid; Ali Mortazavi.  “A Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Cardiology Care For Patients With Coronary Heart Disease” (poster presentation), 10th Annual Health Services and Outcomes Research Conference: Improving the Quality of Health Care: The Patient’s Perspective, Houston, Texas, December 2, 2009.

Amber Wave Dwairy, Kim K. Birtcher, Loriann M. Furman, Ali Mortazavi, MD. “Potential Interaction Between Clopidogrel and Proton Pump Inhibitors,” (student poster presentation), 10th Annual Health Services and Outcomes Research Conference: Improving the Quality of Health Care: The Patient’s Perspective, Houston, Texas, December 2, 2009.

Kandi K. Icenhower, Kim K. Birtcher, Loriann M. Furman, Madjid Mirzai-tehrane, MD. “Aggressive Management of Very High Triglycerides (>500 mg/dL) to Prevent Acute Pancreatitis” (student poster presentation), 10th Annual Health Services and Outcomes Research Conference: Improving the Quality of Health Care: The Patient’s Perspective, Houston, Texas, December 2, 2009.

H. Chen, V. Saundankar, D. Bhowmik, K. Birtcher, L. Radican, Y. Qiu. “Efficacy and Tolerability of Alpha-Glucosidase Inhibitors: A Systematic Review and Meta-Analysis of Clinical Trials” (poster presentation), International Diabetes Federation 20th World Diabetes Congress, Montreal, Canada, October 2009.

H Chen, Y Qiu, D Bhowmik, K Birtcher, A Mortazavi. “Quantify Relationship Between HbA1C and Macrovascular Events” (poster presentation), American Diabetes Association Scientific Sessions Meeting, New Orleans, LA, June 6, 2009.

JL Brennan, KD Milliorn, KK Birtcher.  “Enoxaparin Patient Education Form for Education to Patient from Pharmacist Upon Hospital Discharge” (student poster presentation), ASHP Midyear Clinical Meeting; December 10, 2008; Orlando, Florida

JK Dunn, A Alvidrez, KK Birtcher. “Patient-specific, customizable, electronic form allows for better patient education and documentation in a pharmacist managed warfarin clinic” (student poster presentation), Kelsey Research Foundation’s  9th Annual Health Services & Outcomes Research Conference: December 3, 2008; Houston, TX

LM Furman, KK Birtcher, O Wehmanen, A. Greisinger, A Nayak, M. Mirzai-tehrane, H. Rashid, A. Mortazavi. “Secondary prevention lipid clinic changes therapy for patients at risk for drug interaction after FDA Medwatch warning” (poster presentation), Kelsey Research Foundation’s  9th Annual Health Services & Outcomes Research Conference: December 3, 2008; Houston, TX

A.D. Raju, S.S. Sansgiry, M. Mirzai-tehrane, H. Rashid, A. Mortazavi, K.K. Birtcher. “Clinical Predictors of Health Related Quality of Life in Patients With Cardiac Disease and Dyslipidemia”(graduate student poster presentation), International Society for Pharmacoeconomics and Outcomes Research 13th Annual International Meeting, Toronto, ON, Canada, May 6, 2008.

L.M. Furman; D.M. Martinez; G. Rice; A. Nayak; M. Mirzai-tehrane; H. Rashid; A. Mortazavi; K.K. Birtcher.  “Secondary Prevention Lipid Clinic Provides Influenza Vaccinations to High Risk Patients with Coronary Heart Disease” (poster presentation), Kelsey Research Foundation’s  8th Annual Health Services & Outcomes Research Conference; November 6, 2007; Houston, Texas

K.K. Birtcher, J.T. Sherer, O. Wehmanen, B. Brehm, A. Greisinger, G. Rice, M. Mirzai-tehrane, H. Rashid, and A. Mortazavi. “Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very-High Risk Patients with Diabetes and Coronary Heart Disease” (poster presentation), National Lipid Association Meeting, Scottsdale, AZ, June 2, 2007.

K.K. Birtcher, J.T. Sherer, O. Wehmanen, B. Brehm, A. Greisinger, G. Rice, M. Mirzaitehrane, H. Rashid, A. Mortazavi. “Secondary Prevention Lipid Clinic Reaches LDL-C Goals more often than Usual Care for Very High Risk Patients with Diabetes and Coronary Heart Disease” (poster presentation), Kelsey Research Foundation’s 7th Annual Health Services & Outcomes Research Conference, Houston, Texas, Nov. 14, 2006.

A. Greisinger, B. Brehm, K. Birtcher, O. Wehmanen, M. Mirza-tehrane, H. Rashid, A Mortazavi. “Treatment Outcomes in a Secondary Prevention Lipid Clinic (poster presentation), Academy of Health Services Research Conference; June 25, 2006; Seattle Washington

K.K. Birtcher, W. Pan, K.A. LaBresh, G. Ellrodt. “Global Improvement in Cardiac Care is Seen in Get With The Guidelines Hospitals: Additional Performance Measures in Patients Hospitalized for Coronary Heart Disease” (poster presentation), American Heart Association’s 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Meeting, Washington, D.C., May 8, 2006.

K. Birtcher, M. Massumi, S. Sansgiry, M. Mirzai-tehrane, H. Rashid, A. Mortazavi. “Secondary Prevention Lipid Clinic in Collaboration With Pharmacists Addresses Risk Factors in a Cardiology Practice Better Than Usual Cardiology Care” (poster presentation), University of Houston College of Pharmacy Silver Anniversary Celebration, Houston, Texas, November 11, 2005.

S. Loughlin, A. Mortazavi, K. Garey, G. Rice, K. Birtcher. “Influenza Vaccination Rates in High-risk Cardiovascular Patients Before and After a Pharmacist Vaccination Program (poster presentation), American College of Clinical Pharmacists meeting; October 2005; San Francisco, California

A. Greisinger, A. Mortazavi, K. Birtcher, H. Rashid, M. Mirza-tehrane, O. Wehmanen, B. Brehm. “Secondary Prevention Lipid Clinic: A Multidisciplinary Approach” (poster presentation), Academy of Health Services Research Conference; June 2005

Other Presentations

The Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: ACC Expert Consensus Decision Pathway - A Dialogue with the Experts (enduring continuing education webinar) in 4 vignettes; American College of Cardiology, December 2016

Case Studies: The Role of Non-Statin Therapies for LDL-C Lowering in the Management of ASCVD Risk, American College of Cardiology New York Cardiovascular Symposium Pre-Conference; New York, New York; December 8, 2016

Case Studies in the Management of Hypercholesterolemia: The Role of Non-statin Therapies, The Changing Landscape of Hypercholesterolemia - The Emerging Role of Non-Statin Therapies; American Society of Health-System Pharmacists Midyear Clinical Meeting; Houston, Texas; December 6, 2016

Lipid Lowering Medications and Interactions; Baylor College of Medicine’s Atherosclerosis Fellows Core Curriculum; Houston, Texas; September 26, 2016

Panelist, Reading Between the (Guide)Lines: Challenging Cases Beyond the Evidence; ACC. 16, Scientific Session, Syncope: Case Study Based Learning; Chicago, IL; April 4, 2016

Case presentations, No Patient Left Behind: Management of High-risk Patients with Residual Risk; ACC.16, Clinical Focus Session, The Role of Combination Therapy in Dyslipidemia: A Framework for Clinical Decision-Making; Chicago, IL; April 2, 2016

Panelist, ACC.16, Clinical Focus Session, The Role of Combination Therapy in Dyslipidemia: A Framework for Clinical Decision-Making; Chicago, IL; April 2, 2016

Panelist, Reading Between the (Guide)Lines: Challenging Cases Beyond the Evidence; ACC. 16, Scientific Session, Beyond Atherosclerotic CAD - Role of the Microvasculature; Chicago, IL; April 2, 2016

Best Medication Strategies for Residual Angina: What can the new Stable Ischemic Heart Disease Guidelines Tell Us?; ACC. 16, Scientific Session, Beyond Atherosclerotic CAD - Role of the Microvasculature; Chicago, IL; April 2, 2016

Panelist, ACC. 16, Scientific Session, Beyond Atherosclerotic CAD - Role of the Microvasculature; Chicago, IL; April 2, 2016

Lipid Lowering Medications and Interactions; Baylor College of Medicine’s Atherosclerosis Fellows Core Curriculum; Houston, Texas; February 29, 2016

Our Journey Towards Provider Status; Pharmacy Practice and Translational Research Conference; Houston, Texas; January 21, 2016

Practical Issues for Combination Therapy; American College of Cardiology, LDL: Address the Risk Think Tank; Washington, D.C.; September 16, 2015

Managing Very High Triglycerides; American College of Cardiology Very High Triglyceride Think Tank; Washington, D.C.; August 24, 2015

Patient Guide to Safe Use of Omega-3 Fish Oil (enduring webinar); American Pharmacists Association Practice Tools; July 2015; http://pharmacist.com/practice-tools

Contemporary Pharmacy Practice: Secondary Prevention Lipid Clinic; University of Houston College of Pharmacy Faculty Retreat; Houston, Texas; May 22, 2015

Hypertriglyceridemia and CVD Risk: Are Triglycerides Rocking the Cardiovascular Boat?; American Society of Health-System Pharmacists; Anaheim, California; December 9, 2014.

Overview of Training for Pharmacists. American College of Cardiology - Team Based Care Think Tank. Washington, D.C.; November 7, 2014.

Models of Team Based Care and What They Can Teach Us. American College of Cardiology - Team Based Care Think Tank Draft Agenda. Washington, D.C.; November 7, 2014.

The Nuts and Bolts of Omega-3 Fatty Acids in Hypertriglyceride Treatment; Medscape Education, CME/CE Activity for March 26, 2014. http://www.medscape.org/ viewarticle/822066?src=wnl_cme_revw.

Secondary Prevention Lipid Clinic: Contributions to Accountable Care; Baylor College of Medicine's conference, Treatment of the Patient with Severe Dyslipidemia: What at the Unmet Clinical Needs?; Houston, Texas; March 20, 2014

Gaps in Care: How Do They Occur? American College of Cardiology LDL Address the Risk Think Tank: Washington, D.C., October 10, 2013

Secondary Prevention Lipid Clinic: Contributions to Accountable Care; Baylor College of Medicine's conference, Treatment of the Patient with Severe Dyslipidemia: What at the Unmet Clinical Needs?; Houston, Texas; September 24, 2013

Providing High Quality, Cost-Effective, Team-Based Outpatient care; American College of Cardiology Anticoagulation Roundtable: Washington, D.C., September 21, 2013

Lipid Lowering Medications and Interactions; Baylor College of Medicine’s Atherosclerosis Fellows Core Curriculum; Houston, Texas; October 15, 2012

Clinical Pharmacy; University of Houston Asian Medical Professional Society; February 21, 2012

Secondary Prevention Lipid Clinic: A Multidisciplinary Approach; Kelsey Research Foundation’s Frontiers in Cardiology; Winter Park, Colorado; January 6, 2012

Evaluation and Management of Atherogenic Risk in Patients With Metabolic Syndrome and Diabetes Mellitus, American Heart Association’s Spotlight Series; Tomball, Texas; September 14, 2011

Evaluation and Management of Atherogenic Risk in Patients With Metabolic Syndrome and Diabetes Mellitus, American Heart Association’s Spotlight Series; Deenton, Texas; January 27, 2011

Secondary Prevention Lipid Clinic: A Multidisciplinary Approach; Kelsey Research Foundation’s Frontiers in Cardiology; Winter Park, Colorado; January 8, 2011

Beyond LDL-C: The Value of Measuring Other Atherogenic Lipoproteins and markers of Atherogenic Risk, American Heart Association’s Spotlight Series; Denton, Texas; December 16, 2010

Lipid Lowering Medications; Baylor College of Medicine’s Atherosclerosis Fellows Core Curriculum; Houston, Texas; September 29, 2010 Poster Presentations; ABCs of Residency Workshop; Houston, Texas; September 27, 2010

Core Concepts, American Association of Diabetes Educators, co-taught with Barb Schreiner, R.N. & Cecilia Sauter, R.D., Chicago, Illinois, April 2010.

“Genetic Variation and Statin Side Effects”, National Lipid Association Winter Lipid Update; February 20, 2010; San Francisco, CA

“Beyond LDL-C: The Value of Measuring Other Atherogenic Lipoproteins and markers of Atherogenic Risk”, American Heart Association’s Spotlight Series; January 20, 2010; Brenham, Texas

“Evaluation and Management of Atherogenic Risk in Patients With Metabolic Syndrome and Diabetes Mellitus”, American Heart Association’s Spotlight Series; January 13, 2010; Brenham, Texas

“Secondary Prevention Lipid Clinic: A Multidisciplinary Approach”; presentation at the Kelsey Research Foundation’s Frontiers in Cardiology; January 9, 2010; Winter Park, Colorado

“Improving Patient Adherence”; 2 workshop presentations at the 10th Annual Health Services and Outcomes Research Conference: Improving the Quality of Health Care: The Patient’s Perspective; December 2, 2009; Houston, Texas

Core Concepts, American Association of Diabetes Educators, co-taught with Barb Schreiner, R.N. & Cecilia Sauter, R.D. October 21-23, 2009, Orlando, Florida

Core Concepts, American Association of Diabetes Educators, co-taught with Virginia Zamudio Lange, R.N. & Cecilia Sauter, R.D., Chicago, Illinois, March 24-26, 2009.

“Getting to the Heart of Quality,” presentation and served as moderator at the American Heart Association’s Getting to the Heart of Quality: Turning Guidelines into Lifelines, San Antonio, Texas, March 6, 2009.

“Lipid Clinics Update,” presentation at the Kelsey Research Foundation’s Frontiers in Cardiology, Winter Park, CO, January 10, 2009.

The Roles of Healthcare Providers in Lipid Management, presentation at the Roche Preceptorship, Baylor College of Medicine; November 21, 2008; Houston, Texas

Core Concepts, American Association of Diabetes Educators, co-taught with David Miller, R.N. & Nadine Uplinger, R.D.; October 14-16, 2008; Philadelphia, Pennsylvania

 “Getting to the Heart of Quality: Our Journey” presentation and served as moderator at the American Heart Association’s Getting to the Heart of Quality: Turning Guidelines into Lifelines; October 3, 2008; Houston, Texas

Core Concepts, American Association of Diabetes Educators, co-taught with Barbara Schreiner, R.N. & Patricia Geil, R.D.; March 25-27, 2008; Houston, Texas

“Getting to the Heart of Quality: Our Journey”; presentation and served as moderator at the American Heart Association’s 4 State Conference; February 25-26, 2008; Dallas, Texas

“Hyperlipidemia: Applying the Principles of the AADE7”; a webinar for the American Association of Diabetes Educators; January 9, 2008.

 “Sharpening Your Quality Improvement Methodology,” a pre-conference workshop for the American Heart Association Practical Approaches to Improving Stroke Care, Nov. 2, 2007, Syracuse, N.Y.

“Team Dynamics: Assessing Composition & Improving Buy-In,” Facilitator for the American Heart Association Practical Approaches to Improving Stroke Care, Oct. 30, 2007, Providence, RI.

“Sharpening Your Quality Improvement Methodology,” a pre-conference workshop for the American Heart Association Practical Approaches to Improving Stroke Care, Providence, RI, Oct. 30, 2007.

Core Concepts, American Association of Diabetes Educators, co-taught with Barbara Schreiner and Patricia Geil, Chicago, IL, Sept. 24–26, 2007.

Advanced Practice Clinic on Lipid Management, a pre-conference workshop for the American Association of Diabetes Educators Annual Meeting, co-taught with Salim S. Virani, St. Louis, MO, July 31, 2007.

K.K. Birtcher and B.J. Jackson, “Who’s In Control? – Enhancing Patient Adherence” (presentation), National Lipid Association Meeting, Scottsdale, AZ, June 1, 2007.

“Quality Improvement Initiative: Secondary Prevention Lipid Clinic”, presentation to the Accreditation Association for Ambulatory Health Care, Kelsey-Seybold Clinic; October 2, 2006; Houston, Texas

“Involving the Hospital Pharmacy in Your Get With The Guidelines Team”, The American Heart Association Texas Affiliate – state teleconference; September 12, 2006

“Pharmacist-Managed Lipid Clinic in a Cardiology Office”.  Pfizer 2006 Pharmacy Residents’ Program; August 17, 2006; Houston, Texas.

“Global Improvement in Cardiac Care is Seen in Get With The Guidelines Hospitals: Additional Performance Measures in Patients Hospitalized for Coronary Heart Disease,” The American Heart Association GWTG Program Results and New Science from Outcomes and ACC Conferences National Teleconference, July 18, 2006.

 “Get With The Guidelines – Heart Failure”, moderator.  The American Heart Association; April 13, 2006; Houston, Texas

“Secondary Prevention Lipid Clinic”, Round Table leader.  Texas Society of Health-Systems Pharmacist, Student Section; April 2, 2006; Galveston, Texas.

“Get With The Guidelines Quality As A Business Model”, moderator.  The American Heart Association & Tenet Healthcare Foundation Hospital Leadership Breakfast; March 22, 2006; Houston, Texas

“Getting Patients to Goal: A Secondary Prevention Lipid Clinic Perspective”; presented at Kelsey-Seybold Clinic’s Promoting Healthy Living workshop; February 4, 2006; Houston, Texas

“Pharmacy Management”, presented to the Vietnamese American Pharmacy Student Society at University of Houston College of Pharmacy; February 2, 2006; Houston, Texas

Published Abstracts

Kim K. Birtcher, Anthony Greisinger, Brenda J. Brehm, Oscar Wehmanen, Loriann M. Furman; Cathryn C. Salinas, Madjid Mirzai-tehrane, Atasu Nayak, Haroonur Rashid, Ali Mortazavi. “A Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Cardiology Care For Patients With Coronary Heart Disease; Journal of Lipidology 2007:1:148-167 (#202).

K.K. Birtcher, W. Pan, K.A. LaBresh and G. Ellrodt. “Global Improvement in Stroke Care is Seen in Get With the Guidelines Hospitals: Potential Performance Measures in Patients Hospitalized for Acute Ischemic Stroke” Circulation 2007;115:e550 (abstract 242).

K.K. Birtcher, W. Pan, K.A. LaBresh, G. Ellrodt. Global Improvement in Cardiac Care is Seen in Get With The Guidelines Hospitals: Additional Performance Measures in Patients Hospitalized for Coronary Heart Disease. Circulation 113:e797–8 (abstract P53), 2006.

Memberships

  • Accreditation Council for Clinical Lipidology
  • American Association of Colleges of Pharmacy
  • American Association of Diabetes Educators
  • American College of Cardiology
  • American College of Clinical Pharmacists
  • American Diabetes Association
  • American Heart Association
  • American Society of Health-Systems Pharmacists
  • Emerging Science of Lipid Management
  • Gulf Coast Society of Health-Systems Pharmacists
  • National Lipid Association
  • Southwest Lipid Association
  • Texas Society of Health-Systems Pharmacists

Appointments

  • Editorial Board Member, Journal of Lipidology, 2006-present
  • Associate Editor, Cardiovascular Drugs Section, Tarascon Pocket Pharmacopoeia

Professional Service

Accreditation Council for Clinical Lipidology

  • Appointed to the Board of Governors, 2016 - 2019

American Association of Colleges of Pharmacy

  • Faculty Delegate to Annual Meeting, 2007, 2009


American Association of Diabetes Educators

  • Instructor, Core Concepts Courses, 2007 – 2010
  • Reviewer, ABCs of Diabetes Education, 2008
  • Reviewer, Continuing Education Programs for pharmacists, 2008 – 2011


American College of Cardiology

  • Appointed to the ACC/AHA Taskforce on Practice Guidelines, January 2015
  • Appointed to the Best Practice and Quality Improvement Subcommittee, April 2011 – April 2013
  • Chair, Cardiovascular Team Section’s Working Group for Clinical Pharmacists, May 2010 – 2013
  • Member, Cardiac Care Associate (CCA), 2007 – present
  • Appointed to the Cardiac Care Team Committee, April 2008 – March 2011
  • Cardiac Care Associate Designation Work Group, 2008 – 2009


American Heart Association (AHA)

  • Appointed to the ACC/AHA Taskforce on Practice Guidelines, January 2015
  • Appointed to Get With the Guidelines Quality Improvement Subcommittee for 2008 – 2013
  • Appointed to the Professional Education Committee, October 2008 – June 2011
  • Appointed to the Education Panel for the educational program - Spotlight Series


Southwest Lipid Association (SWLA)

  • Member, Board of Directors, 2006 – 2011
  • Member, Planning Committee for annual seminar, 2008 – 2009